Tapentadol hydrochloride: A novel analgesic
Open Access
- 1 January 2013
- journal article
- review article
- Published by Medknow in Saudi Journal of Anaesthesia
- Vol. 7 (3) , 322-6
Abstract
Tapentadol is a novel, centrally acting analgesic with dual mechanism of action, combining mu-opioid receptor agonism with noradrenaline reuptake inhibition in the same molecule. It has an improved side effect profile when compared to opioids and nonsteroidal anti-inflammatory drugs. The dual mechanism of action makes Tapentadol a useful analgesic to treat acute, chronic, and neuropathic pain.Keywords
This publication has 30 references indexed in Scilit:
- Emerging concepts in post-operative pain managementIndian Journal of Anaesthesia, 2011
- Mu-opioid and noradrenergic α2-adrenoceptor contributions to the effects of tapentadol on spinal electrophysiological measures of nociception in nerve-injured ratsPain, 2011
- Population Pharmacokinetics of Tapentadol Immediate Release (IR) in Healthy Subjects and Patients with Moderate or Severe PainClinical Pharmacokinetics, 2010
- Cost-effectiveness analysis of tapentadol immediate release for the treatment of acute painClinical Therapeutics, 2010
- Tapentadol immediate release: a new treatment option for acute pain managementJournal of Pain Research, 2010
- Tolerability of tapentadol immediate release in patients with lower back pain or osteoarthritis of the hip or knee over 90 days: a randomized, double-blind studyCurrent Medical Research and Opinion, 2009
- Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: A 10-day, phase III, randomized, double-blind, active- and placebo-controlled studyClinical Therapeutics, 2009
- The Prevalence, Severity, and Impact of Opioid-Induced Bowel Dysfunction: Results of a US and European Patient Survey (PROBE 1)Pain Medicine, 2009
- (–)-(1 R,2 R)-3-(3-Dimethylamino-1-ethyl-2-methyl-propyl)-phenol Hydrochloride (Tapentadol HCl): a Novel μ-Opioid Receptor Agonist/Norepinephrine Reuptake Inhibitor with Broad-Spectrum Analgesic PropertiesThe Journal of Pharmacology and Experimental Therapeutics, 2007
- The burden of acute postoperative pain and the potential role of the COX-2-specific inhibitorsRheumatology, 2003